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Conclusions: (1) The Localmed Infusion Sleeve enables drug infusion to
be uncoupled from balloon dilatation. (2) Successful delivery of Urokinase
to the vessel wall may be achieved using this device without the need for
catheter exchange. 13} Persistence of urokinase within the vessel wall occurs
after local delivery.
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Local Delivery of Urokinase to Porcine Coronary
Arteries Using the Localmed infusion Sleeve
Michael A. Azrin, Joseph F. Mitchel, Laurine M. Bow, Tod V Alberghini,
Gordon Grant, Aaron V Kaplan, David D. Waters, Raymond G. McKay. Hartford
Hospital, Hartford, CT; University of Connecb'cut, Farmington, CT
this device, 1231-urokinase was delivered to 19 coronary arteries in 10 anes-
thetized pigs. All vessels underwent dilation at 6 atm, with simultaneous in-
fusion of urokinase. Drug was infused at an inflation pressure of 2 or 4 atm,
a balloon:artery ratio of either 1:1 or 1.2:1. and at a concentration of either
5,500 or 11,000 units/ml. Treated vessels were harvested up to 5 hrs later to
quantitate intramural drug deposition and washout.
Results: Successful drug delivery was accomplished in all vessels without
adverse hemodynamic, electrical, or angiographic sequelae. The efficiency
of drug delivery (i.e., % of delivered drug that was intramurally deposited)
ranged from 0.06 to 0.4%. Drug infusion pressure had no significant effect on
drug deposition. Higher urokinase concentrations and a higher balloon :artery
ratio resulted in higher intramural drug levels (p < 0.01). Urokinase deposition
and washout is described below:
Conclusions: Urokinase can be safely delivered at coronary angioplasty
sites using the Channelled balloon. Intramural drug deposition is related to
the concentration of infused drug and balloon:artery ratio. Although signif-
icant washout occurs, urokinase persists for at least 5 hours following de-
livery. This technique may be useful in the local dissolution of intracoronary
thrombus and creates a reservoir of urokinase at an angioplasty site which
may result in prolonged local thrombolysis.
Local Delivery of thrombolytic agents may reduce thrombus formation after
balloon angioplasty. The Localmed Infusion Sleeve enables localized infusion
of urokinase to be performed at the time of balloon angioplasty without the
need for catheter exchange. Methods: Balloon angioplasty was performed
on 13 coronary arteries of 5 pigs at 4 atmospheres with a balloon to artery
ratio of approximately 1.1 to 1. After angioplasty the Infusion Sleeve was
advanced over the dilatation balloon and the balloon was reinflated to 2 at-
mospheres to appose the sleeve to the vessel wall. 50,000 Units (8 ccl of
1231-urokinase was infused through the microperforations in the sleeve for
10 seconds by a computer controlled pump. The coronaries were then ex-
cised and counted in a gamma counter.
Results:
Paul A. Gurbel, Frank 1. NaveUa, Brent Muhlstein, Alan N. Tenaglia, David W. MUller,
Eric R. Bates, Charles J. Davidson, Michael J. Miller, Frank V Aquirre, James
B. Hermiller, Carl Tommaso, Lisa Berdan, Paul Owens, Glenn J. Beauman, Jeffrey
D. Lelmberger, Edwin BOVill, E. Magnus Ohman. University of Maryland, Baltimore,
MD: Duke University Medical Center, Durham, NC
PTCA in the setting of unstable angina (UA) and coronary thrombus (CT) is as-
sociated with adverse outcomes. We performed a pilot study of intralesional
tPA (20 mg) using an end-hole infusion (Tracker) catheter and intracoronary
heparin 15,000 units). delivered over 20 mins, prior to PTCA in 53 pts with
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Exercise Performance Predicts Long-term
Prognosis in Patients with PTCA for Multivessel
Disease
# Kaplan-Meier, 'p = 0.0000 by log-rank test
Age >= 65 (N = 154) Age < 651N ~ 290) p-value
% Imean) % (mean)
Age (years) 169.7) (53.91 0000
Male Gender 51.9 73.8 0000
Never Smoked 39.0 266 0.007
Prior MI 35.7 328 0.531
Hypertension 46.7 355 0.023
Non-O-Wave MI 31.4 403 0.063
Abnormal ECG 92.9 94.1 0597
LV EF (613) (58.7) 0038
2-3 Vessel Disease 50.0 36.0 0005
Angiographic Success 95.5 96.4 0.689
Events by 42 days
Death 1.3 14 0.938
MI 6.5 55 0.671
Stroke 0.0 0.3 0463
CABG 1.3 4.2 0.102
Death/MllStroke/CABG 8.4 9.0 0864
patients, n
8 yr survival#, %
8 yr surv. without MI or CABG#, %
In comparison to younger pts., elderly pts having PTCA in TIMIIIIB were
more often female, had not smoked, had history of hypertension and had
multivessel coronary disease. The results of PTCA were equally excellent in
both groups. Thus, advanced age alone does not adversely affect the results
of PTCA in selected pts with acute ischemic syndromes.
Christoph Kadel, Andrea Wolf, Rainer Schrader. University Hospital Frankfurt am
Main FRG
The aim of the study was to evaluate whether exercise performance
(watts*minl close to the time of PTCA predicts long-term prognosis in P with
multivessel disease (MVD). 1031 (study group) of 1252 consecutive P with
MVD and PTCA during 1977-90 underwent an exercise ECG. Exercise was
performed with a constantly maintained workload and terminated at severe
angina, ST.j, ;::3 mm, or at 6 min. Completeness of revascularization was
established by reangiograms in 564n96 successful P. Long-term follow-up,
ascertained by questionnaire in 97.9%, ranged from 2-15 (median 4.8) yrs.
Results. Univariate analyses revealed a strong correlation between exer-
cise performance and long-term prognosis:
Cox's multivariate regression determined exercise performance as the
most important predictor of long-term survival, p = 0.0000, followed by 3VD,
P = 0.001, and age, p = 0.01. Survival without MI or CABG was predicted
by completeness of revascularization, exercise performance, and acute suc-
cess, each p = 0.0000, and by 3VD, P = 0.02.
Conclusion. The functional parameter of exercise performance was a more
powerful predictor of long-term survival after PTCA in P with MVD than angio-
graphic parameters such as 3VD or completeness of revascularization and
therefore should be considered, if algorithms for estimation of long-term
outcome are designed.
The Channelled Balloon is a new local drug delivery catheter which allows for
simultaneous vessel dilation and local drug infusion at low pressure. In or-
der to assess the pharmacokinetics of intracoronary urokinase delivery with
1 1001-231 Localized Intracoronary Delivery of Urokinase
with the Channelled Balloon: Pharmacokinetics
of Drug Delivery and Washout
Joseph F. Mitchel, Daniel B. Fram, Michael A. Azrin, Laurine Bow, Tod Alberghini,
Adel M. Eldin, Michael Shwedick, David D. Waters, Raymond G. McKay. Hartford
Hospital, University of Connecticut, Hartford, er
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'p ~ 0.001, "p ~ 0.007, '''p ~ 0.07 (All comparison made with preceding group)
Edward A. Chasteney, PS. Ravichandran, Deborah Tuke Bahlman, Alan Shearin,
Kenton W. Gregory. Oregon Health Sciences University, Oregon Medical Laser Center,
Department of Veterans Affairs Medical Center; Portland, Oregon
Stenotic Lesions Reliably Form in Porcine
Coronary Arteries Using Copper Stents or
Intracoronary Heating
Prevention of Subacute Stent Thrombosis by
Polymer-Polyethylene Oxide-Heparin Coating in
the Rabbit Carotid Artery
Occlusion 90 min postLT
Global EF 0.49 ± 0.09 0.55 ± 0.04 NS
Index 17± 0.1 1.1 ±01 (p < 0.051
Grafted Region Wall Motion 4 1 (p < 001)
%Wall Thick. -5 31 (p < 0.01)
Inflammation Calcification Neovascular Fibrosis Necrosis
H C H C H C H C H C
Intima 3% 90%:1: 3% 50%; 3% 65%:1: 3% 50%:1: 11% 5%
Media 25% 95%; 22% 5% 11% 63%:1: 8% 74%* 69% 26%*
Adventitia 69% 70% 11% 5% 17% 40%* 64% 55% 11% 5%
11001-281
Michael E. Staab, Daniel K. Meeker, William D. Edwards, Sanjay S. Srivatsa, Myung
Ho Jeong, David R. Holmes Jr., Robert S. Schwartz. Mayo Clinic and Foundation,
Rochester, MN
The capability of creating stenotic lesions in an animal model is essential
to testing new interventional devices. We developed a coronary stenosis
model in domestic swine using either heated balloon angioplasty (heat) at
high-temperature (80°C for 15 seconds) or copper stents (copper). Animals
were sacrificed 14-47 days after artery injury. Morphometric and histologic
study of the stenoses created by heat (14 pigs, 33 arteries) and copper (9
pigs, 18 arteries) was performed. Measurement of lumen area and area cir-
cumscribed by the internal elastic lamina (IEL) was used to calculate steno-
sis by l-{lumen/IEL). Mean stenosis from heat was 66.9 ± 27% and copper
80.7 ± 22%. Stenoses exceeding 50% were produced by heat 78.8% and
copper stents 87.5% of the time. Histologically, the heat group was notable
for concentric intimal hyperplasia, intact elastic laminae, necrosis of medial
cells, calcific deposits in the media, and mild adventitial inflammation and fi-
brosis. Copper stent lesions demonstrated severe diffuse inflammation, de-
struction of the elastic laminae, neovascularization, and mild intimal calcifi-
cation around stent tines.
Percent of Arteries with Histologic Feature
Conclusion: Heated balloon angioplasty or deployment of copper stents
into swine coronary arteries reliably creates severe stenoses suitable for test-
ing new interventional devices. Copper stents in particular create very tight
and complicated lesions that would challenge new devices. The histopathol-
ogy differs with copper demonstrating destructive inflammatory lesions vs.
orderly intimal hyperplasia and medial calcification observed in heat lesions.
Conclusions: 1) LT is able to rapidly remove large amounts of thrombus
in CABG. 2) Thrombus removal by LT does not cause detectable changes in
regional cardiac function. 3) High patency rates persist 90 min. post L1.
Fisher's Exact Test, two-sided: 'P::5 0.05,;p::5 0.0001 H ~ Heat C ~ Copper
Sushll Sheth, Vishva Dev, Harvey Jacobs, James S. Forrester, Frank Litvack, Neal
L. Eigler. Cedars-Sinai Medical Center, Los Angeles, CA; University of Utah, Salt Lake
City, UT
Our goals were to develop a rabbit model of subacute stent thrombosis and
to evaluate the efficacy of a polymer stent coating with covalently bound
heparin for its prevention. Bare metal stents (a nitinol wire coil with 3 stain-
less steel joints) were implanted in a carotid artery of 10 NNJ rabbits with a
3.0 mm balloon catheter, inflated twice at 6 atm for 1 minute. Systemic an-
tiplatelet and antithrombotic therapy was withheld. Animals were sacrificed
at 24, 72 and 96 hours. Only the 96 hour group consistently developed occlu-
sive or subocclusive thrombosis. Heparin (0.28 J.l.g/cm2j was linked onto the
surface of soluble polymer chains of segmented polyurethaneurea (SPUU)
or aliphatic Tecoflex polyurethane membrane (50 J.l.m thick). using polyethy-
lene oxide (PEO) as a hydrophilic spacer group. Eight stents were coated
with this polymer-PEO-Heparin coating. Eight bare metal stents and 8 coated
stents were deployed in a carotid artery of 16 NNJ rabbits. All animals were
sacrificed at 96 hours. At the time of sacrifice, both carotids (stented and
contralateral nonstented) were exposed and resting blood flow measured.
The amount of thrombus on each stent was assessed by a semiquantitative
grading scale (I: no lumen encroachment; II: lumen encroachment; III: sub-
occlusive thrombus; IV: occlusive thrombus) and by the weight of the dry
thrombus.
Results:
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Rapid Thrombolysis in Experimental Coronary
Artery Bypass Grafts
Baseline Post-tPA Post-PTCA
TIMI Thrombus Scale 2.2 ± 1.0 1.6 ± 1.2" 0.5 ± 0.9'
MLD by QCA (mm) 0.82 ± 0.42 0.89 ± 0.57'" 1.90 ± 0.59'
TIMI Grade Flow 2.6 ± 0.8 2.5 ± 1.0 2.9 ± 0.5
UA and C1. Full delivery of tPA and heparin was possible in 47 pts. Activated
clotting time was >300 sec in all pts. PTCA was performed in 48 pts 20 mins
after completion of the infusion. Systemic fibrinogenolysis (fibrinogen pre
408 ± 120 mg/dL, post 398 ± 114) and thrombin activation (no increase in
fibrinopeptide A or fragment 1.2) did not occur but prolonged clot lysis was
evident (D-Dimer pre 196 ± 179 ng/mL. 4 hours post 849 ± 746, P = 0.0001).
Angiographic outcomes were (mean ± SO):
PTCA was successful «50% residual stenosis) in 87% and 6% had a major
bleeding event. In-hospital outcomes were as follows: death 0, myocardial
infarction 4%, abrupt reclosure 11 %, repeat PTCA 11 %, and CABG 6%.
Conclusion: Intralesional tPA with intracoronary heparin causes prolonged
thrombolysis without thrombin activation and reduces the extent of coronary
thrombus in the setting of unstable angina. It is associated with a high PTCA
success rate and favorable in-hospital outcome. Further investigations of this
method of local adjunctive thrombolysis and PTCA are warranted.
Local Dissolution of Intracoronary Thrombus
with Urokinase Using the Dispatch'· Catheter:
Clinical Studies
Joseph F. Mitchel, Daniel B. Fram, Jeffrey A. Hirst, FrancIs J. K,eman,
Charles Primiano, Adel M. Eldin, David D. Waters, Raymond G. McKay. Hartford
Hospital, University of Connecticut Hartford, CT
The Dispatch'· Catheter is a new local drug delivery device which allows
for the prolonged infusion of therapeutic agents at an angioplasty site while
still maintaining distal coronary perfusion. To determine the efficacy of this
device in dissolving intraluminal clot with local urokinase infusion, 29 pa-
tients with thrombus-containing stenoses were treated with the Dispatch'·
catheter either prior to (n = 16) or following (n = 13) coronary angioplasty
or directional atherectomy. The study group consisted of 15 males and 14
females with a mean age of 58.1 years. Clinical diagnoses included unstable
angina (n = 14), acute myocardial infarction (n = 11) or post infarction angina
(n = 4). Urokinase was infused at either 10,000 unit/cc (n = 22) or 30,000
units/cc (n = 7) at 0.5 cclmin for up to 30 minutes. All coronary angiograms
were analyzed to determine Thrombus Score (0--3), TIMI flow, and quanti-
tative coronary measurements pre and post Dispatch'· therapy. (Thrombus
Score: 0 = no thrombus, 1 = possible thrombus, 2 = definite thrombus <3
mm,3 = definite thrombus >3 mm).
Results: Infusions of urokinase for 30 mins were well tolerated in 25 pa-
tients without adverse clinical, hemodynamic or electrical sequelae. In the
remaining 4 patients, limited infusions were tolerated only for 2.5, 5, 6 and
11 mins because of chest pain with EKG changes secondary either to side-
branch occlusion or inadequete distal perfusion. For the entire study group,
Thrombus Score decreased from 2.0 ± 0.7 to 0.5 ± 0.8, TIMI Flow increased
from 2.1 ± 1.3 to 3.0 ± 0.0, and minimal lumen diameter increased from 0.70
± 0.59 to 1.58 ± 0.51 mm (all p < 0.01). Distal embolization, no-reflow, and
abrupt closure were not observed in any patient.
Conclusions: Reduction of thrombus-containing stenoses and dissolution
of intracoronary thrombus can be rapidly achieved in patients with infusions
of limited quantities of urokinase with the Dispatch'· catheter. Sidebranch
occlusion and inability to dilate coronary stenoses with inadequate distal per-
fusion may limit the duration of drug infusion with this device.
CABG thrombosis is a common disorder without adequate therapy. To as-
sess the effects of selective laser thrombolysis (LTlin CABG, aortocoronary
bypasses were created and completely thrombosed in nine swine. Maximal
thrombus removal was achieved with pulsed dye laser light (577 nm, 1 J.l.S
pulse, 3 Hz, 64 mJ/pulse) by fluid catheter for 6.7 ± 1 min. Graft flow and
thrombosis were assessed by angio with global and grafted segment my-
ocardial function measured by epicardial echo at constant load. Mean graft
size: 8 mm x 6 cm. Prior to therapy, grafts had no flow (TIMID) and complete
thrombosis for 60 min. TIM I flow post LTwas 2.8 ± 0.4 (p < 0.001) with focal
residual mural thrombus. 90 min post LT, graft appearance and flow were un-
changed. Wall motion (WM) scored from normal (11 to dyskinetic (4). Index
= total WM/14 segments.
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